Publications
.
2020.
Association between side effects and blood microRNA expression levels and their targeted pathways in patients with major depressive disorder treated by a selective serotonin reuptake inhibitor, escitalopram: a CAN-BIND-1 report.. Int J Neuropsychopharmacol.
.
2019. Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants.. Transl Psychiatry. 9(1):254.
.
2019. .
2019. Adjunctive ketamine in electroconvulsive therapy: updated systematic review and meta-analysis.. Br J Psychiatry. 210(6):403-407.
.
2017. .
2017. .
2017. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.. Can J Psychiatry. 61(9):540-60.
.
2016. Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.. BMC Psychiatry. 16:105.
.
2016. .
2016. .
2016. .
2015.
Research-track programs for residents in psychiatry: a review of literature and a report of 3 Canadian experiences.. Can J Psychiatry. 59(5):268-75.
.
2014.